Cephalexin
Product Images NDC 0440-1243

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cephalexin (NDC 0440-1243). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Liberty Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Cephalexin 250 mg 40 Caps For Jazeera 1)

Chemical structure of cephalexin, showing a beta-lactam ring fused to a dihydrothiazine ring with a phenyl group and an amino substituent, along with a water molecule (hydrate form).*

FDA Label Image

Image Label (Cephalexin 250 mg 40 Caps For Jazeera 2)

Cephalexin 250 mg capsules label from Liberty Pharmaceuticals, Inc. The label specifies 40 capsules per package. Each capsule contains 250 mg of cephalexin monohydrate as the active ingredient. The label includes dispensing information fields for doctor, patient, dosage, and administration schedule. Packaging is noted as by Aidarex Pharmaceuticals LLC, Corona, CA. Manufacturer is Jazeera Pharmaceutical Industries, Saudi Arabia. Label includes storage instructions and a description of the capsule appearance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.